News & Announcements
Item 1 of 3
Dr. Michael Seidman is Participating in a New Study to Test Treatment for Blast-induced Tinnitus.
Under the leadership of principal investigator Michael Seidman, MD, AdventHealth Research Institute is participating in the multi-site Clinical Trial of Etanercept (TNF-alpha Blocker) for Treatment of...
Item 2 of 3
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Item 3 of 3
Dr. Kirk Erickson Joins the NavNeuro Podcast to Discuss the Connection Between Physical Activity and Brain Health
Discover insights and guidance on feeling whole in body, mind and spirit, on our blog.
Recent Stories at AdventHealth Research Institute
-
-
PeoplePatricia Robinson, PhD | 50 Most Influential Clinical Executives - 2024 | Modern Healthcare